| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
HORMONES AND SIGNALING
1Veterans Affairs Medical Center, 2Karmanos Cancer Institute, and 3Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan 48201
Submitted 21 August 2003 ; accepted in final form 30 March 2004
Although accumulating evidence suggests a chemopreventive role for folic acid (FA) in colorectal carcinogenesis, the underlying mechanisms are largely unknown. Previously, we reported that supplemental FA inhibits the expression and activation of epidermal growth factor receptor (EGFR) in colon cancer cell lines. To determine the mechanism(s) by which FA affects EGFR function, we have examined whether and to what extent supplemental FA or its metabolites 5-methyltetrahydrofolate (MTF), dihydrofolate (DF), and tetrahydrofolate (TF) will modulate basal and serum-induced activation of the EGFR promoter in the HCT-116 colon cancer cell line. HCT-116 cells were preincubated with or without (control) FA or one of its metabolites (10 µg/ml) for 48 h, transfected with the EGFR promoter luciferase reporter construct, and incubated for 48 h with FA, DF, TF, or 5-MTF in the absence or presence of 10% FBS. Supplemental FA as well as its metabolites markedly inhibited EGFR promoter activity and its methylation status. Exposure of the cells to 10% FBS caused a marked stimulation of EGFR promoter activity and its expression, both of which were greatly abrogated by supplemental FA and 5-MTF. In contrast, serum-induced activation of c-fos promoter activity was unaffected by 5-MTF. The 5-MTF-induced inhibition of serum-mediated stimulation of EGFR promoter activity and EGFR expression was reversed when methylation was inhibited by 5-aza-2'-deoxycytidine. Our data suggest that FA and its metabolite 5-MTF inhibit EGFR promoter activity in colon cancer cells by enhancing methylation. This could partly be responsible for FA-mediated inhibition of growth-related processes in colorectal neoplasia.
colorectal carcinogenesis; methylation; 5-methyltetrahydrofolate
This article has been cited by other articles:
|
|
 |
|
  A. P. N. Majumdar, J. Du, Y. Yu, H. Xu, E. Levi, B. B. Patel, and A. K. Rishi Cell cycle and apoptosis regulatory protein-1: a novel regulator of apoptosis in the colonic mucosa during aging Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1215 - G1222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhang, E. Levi, P. Majumder, Y. Yu, A. Aboukameel, J. Du, H. Xu, R. Mohammad, J. S. Hatfield, A. Wali, et al. Transactivator of transcription-tagged cell cycle and apoptosis regulatory protein-1 peptides suppress the growth of human breast cancer cells in vitro and in vivo Mol. Cancer Ther., May 1, 2007; 6(5): 1661 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wehbe, R. Henson, F. Meng, J. Mize-Berge, and T. Patel Interleukin-6 Contributes to Growth in Cholangiocarcinoma Cells by Aberrant Promoter Methylation and Gene Expression Cancer Res., November 1, 2006; 66(21): 10517 - 10524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z Attias, H Werner, and N Vaisman Folic acid and its metabolites modulate IGF-I receptor gene expression in colon cancer cells in a p53-dependent manner. Endocr. Relat. Cancer, June 1, 2006; 13(2): 571 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Marciniak, A. K. Rishi, F. H. Sarkar, and A. P.N. Majumdar Epidermal growth factor receptor-related peptide inhibits growth of PC-3 prostate cancer cells Mol. Cancer Ther., December 1, 2004; 3(12): 1615 - 1621. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
